Cadernos Cajuína · Nov 10, 2026
Frailty and sarcopenia as predictors of postoperative complications in patients undergoing oncologic surgery: an integrative literature review
By Barbero JB, Filho CODAA, Sejópoles AD et al.
Frailty and sarcopenia represent distinct and partially overlapping dimensions of reduced physiological reserve and may improve risk stratification in patients with cancer who are candidates for surgery. OBJECTIVE: To critically synthesize contemporary evidence on the association of these conditions with complications, mortality, and postoperative recovery, as well as possibilities for assessment and intervention. METHODS: An integrative literature review with targeted consultation of PubMed-indexed records and journal articles and guidelines, prioritizing publications from 2021 to October 2026 and retaining a 2019 diagnostic consensus. The synthesis was thematic, without its own meta-analysis or a claim of an exhaustive search. RESULTS: A meta-analysis of oncologic surgery identified an association between frailty and postoperative complications (adjusted odds ratio of 2.39) and 30-day mortality (3.02). In colorectal surgery, sarcopenia was associated with 30-day morbidity (relative risk of 1.30) and mortality (2.74), although with methodological limitations. Studies from 2025-2026 suggest a reduction in overall complications with multimodal prehabilitation, but the effects on serious events remain uncertain. DISCUSSION: Tools for assessing frailty, muscle strength, physical performance, and body composition are complementary but not interchangeable; tomography findings require standardization and clinical contextualization. CONCLUSIONS: Assessing frailty and sarcopenia before surgery may improve shared decision-making and guide individualized care, without replacing perioperative scores or, in isolation, justifying postponement of cancer treatment.